Indeed, mutations in KCNQ1, KCNH2 and SCN5A genes account for approximately 75% of clinical diagnoses of LQTS, while mutations in the remaining genes account for only 10% of LQTS cases. This evidence concerns the gene KCNH2 and familial long QT syndrome.